NM_004360.5(CDH1):c.421A>C (p.Thr141Pro) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Jul 21, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003340477.2
Allele description [Variation Report for NM_004360.5(CDH1):c.421A>C (p.Thr141Pro)]
NM_004360.5(CDH1):c.421A>C (p.Thr141Pro)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
maltose alpha-D-glucosyltransferase [Streptomyces venezuelae]
maltose alpha-D-glucosyltransferase [Streptomyces venezuelae]gi|1748204271|gnl|PRJNA454547|DEJ44 0|gb|QES08449.1|Protein
-
maltose alpha-D-glucosyltransferase [Bradyrhizobium sp. CCBAU 21365]
maltose alpha-D-glucosyltransferase [Bradyrhizobium sp. CCBAU 21365]gi|1929530832|gnl|PRJNA279921|XI02_ |gb|QOZ21996.1|Protein
-
Rattus norvegicus prostaglandin reductase 2, mRNA (cDNA clone MGC:108784 IMAGE:7...
Rattus norvegicus prostaglandin reductase 2, mRNA (cDNA clone MGC:108784 IMAGE:7189599), complete cdsgi|60552714|gb|BC091173.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024